Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Class I Recall Of Alaris Device Is Pump’s Second In 3 Days

Apr 19 2021

• By Shawn M. Schmitt

Recall Road Sign against sky.

Related Content

US FDA: Recall Of BD Alaris Infusion Pump Is High-Risk Class I

Apr 16 2021

Recent eMDR Change By FDA Asks Adverse Event Reporters About Third-Party Servicers

Nov 24 2020

Additional Topics

Recalls Safety FDA Quality Companies Quality Control Medical Device

More from Recalls

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.